📰 Technogene Ltd News
Technogene Ltd News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Technogene Ltd. Real-time updates on events, politics, business and more.
December 9, 2022
/PRNewswire/ -- The "Recombinant Proteins Market by Product (Growth Factors, Chemokines, Structural Proteins, Membrane Proteins), Application (Drug Discovery &...
December 9, 2022
/PRNewswire/ -- The "Recombinant Proteins Market by Product (Growth Factors, Chemokines, Structural Proteins, Membrane Proteins), Application (Drug Discovery &...
December 6, 2022
DUBLIN--(BUSINESS WIRE)--The "Recombinant Proteins Market by Product (Growth Factors, Chemokines, Structural Proteins, Membrane Proteins), Application (Drug Discovery & Development, Biopharma Production, Research, Diagnostics), End User (Biotech, CROs) - Global Forecast to 2027" report has been added to ResearchAndM...
November 4, 2022
CHICAGO, Nov. 4, 2022 /PRNewswire/ -- Recombinant Proteins Market size is projected to reach USD 2.4 billion by 2027 from USD 1.4 billion in 2022, at a CAGR of 11.4% during the forecast period
November 4, 2022
/PRNewswire/ -- Recombinant Proteins Market size is projected to reach USD 2.4 billion by 2027 from USD 1.4 billion in 2022, at a CAGR of 11.4% during the...
May 18, 2022
Recombinant Proteins Market Research Report by Product (Adhesion Molecules and Receptors, Growth Factors and Chemokines, and Immune Response Proteins),...
December 2, 2021
Recombinant Proteins Market worth $1.7 billion by 2026 – Emerging Trends, Innovations, Key Industry Insights and Opportunities
December 2, 2021
Recombinant Proteins Market worth $1.7 billion by 2026 – Emerging Trends, Innovations, Key Industry Insights and Opportunities
March 8, 2021
Share this article Share this article ResearchAndMarkets.coms offering. The global recombinant proteins market is projected to reach USD 1.7 billion by 2026 from USD 1 billion in 2021, at a CAGR of 9.8% during the forecast period. The market growth is primarily driven by factors such as increasing government investments and R&D expenditure in pharmaceutical & biotechnology companies, growing industry academia collaborations, and the patent expiry of biologic products. Emerging markets in Asian ...
February 16, 2021
The Increasing government investments and R&D expenditure in pharmaceutical & biotechnology companies, growing industry-academia collaborations, and the patent expiry of biologics are the major factors driving the growth of the market. In 2020, the growth factors & chemokines segment accounted for the largest share of the market and is also expected to grow at the highest CAGR during the forecast period. Based on product, the recombinant proteins market is classified into growth factors and che...